2 tracked superinvestors hold CVS HEALTH CORP (CVS), worth $2.6B combined, led by Team. Smart money is holding CVS as of the latest 13F filings.
Current price
$102.81
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor…
Market cap
$105.2B
P/E
59.06
Div yield
2.5%
Revenue YoY
7.8%
Analyst target
$104
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
2
tracked 13F / N-PORT funds
Combined value
$2.6B
disclosed long exposure
Tier-1 conviction
0
concentrated holders
Net this quarter
0
1 buying · 1 selling
Smart money is holding CVS steady this quarter — buys and sells are balanced.
CVS HEALTH CORP (CVS) appears mainly in diversified and quant books here (2 funds, $2.6B combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.
The largest position belongs to Team at 2.2% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 1 added and 1 trimmed, a net add.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Trimmed | 2.2% | $2.4B | |
| Added | 0.6% | $144M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own CVS?
2 tracked funds hold CVS HEALTH CORP (CVS), the largest being Team (Dodge & Cox Stock) at 2.2% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling CVS?
In the most recent 13F quarter, 1 tracked fund added or opened CVS and 1 trimmed it.
How much CVS do tracked funds hold?
Combined disclosed long exposure to CVS across tracked superinvestors is $2.6B as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.